Verified· 2 sources

Selmod GmbH

Summary

About the company

The core activity of Selmod is the development of innovative antibiotics for the treatment of life-threatening, multi-resistant infections. The focus is on the discovery and early clinical development of small molecules and peptides against new target molecules or new mechanisms of action on established or validated target molecules.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered4

Development of new anti-infective therapies

Research and clinical development of new anti-infectives against life-threatening, multidrug-resistant infections, from preclinical research to clinical development up to Phase 2.

Development of new antibiotics

Development of disruptive antibiotics against new targets and on established targets with new mechanisms of action, focused on small molecules and peptides.

Antibiotics for multidrug-resistant bacterial infections

Treatments for carbapenem-resistant Enterobacterales, ESBL-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.

Antifungal therapies for resistant fungal infections

Treatments for drug-resistant Candida spp., including Candida auris, as well as resistant Aspergillus spp. for the treatment of life-threatening fungal infections.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Selmod GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

Selmod GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Selmod GmbH in comparison

Industry comparisons are coming soon

Similar companies